课题基金 / 基金详情

Chemotherapy with Hybrid Liposomes Along with Induction of Apoptosis

Chemotherapy with Hybrid Liposomes Along with Induction of Apoptosis
混合脂质体化疗并诱导细胞凋亡
批准号:
15500335
负责人:
MATSUMOTO Yoko
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MATSUMOTO Yoko的其他基金

相似基金

相关文献

中文摘要
翻译
混合脂质体可以通过简单地超声处理缓冲溶液中的囊泡和胶束分子的混合物来制备。通过改变脂质体的组成,可以控制脂质体的大小、膜流动性、相变温度和疏水性等物理性质,并研究了由亲水性头部基团(磷脂酰胆碱基团)相同、疏水性烷基链不同的磷脂(L-α-二月桂酰磷脂酰胆碱(C<12>_:DLPC)、L-α-二肉豆蔻酰磷脂酰胆碱(C_:DMPC)、L<14>-α-二棕榈酰磷脂酰胆碱(C_<16>:DPPC))和聚氧乙烯十二烷基醚(C_<12>(EO)_<23>)组成的杂化脂质体对人白血病(HL 60)细胞体外生长的抑制作用。由DMPC和聚氧乙烯(10)十二烷基醚(C_<12>(EO)_<10>)组成的杂化脂质体在不使用任何药物的情况下对人早幼粒细胞白血病(HL-60)细胞有明显的抑制作用,通过荧光显微镜和流式细胞仪分析,证实了杂化脂质体在HL-60细胞中的诱导凋亡作用。阐明了脂质体诱导细胞凋亡的途径。细胞凋亡信号首先通过线粒体、caspase-9和caspase-3,再通过Fas、caspase-8和caspase-3到达细胞核。DMPC/C_(EO)_2杂化脂质体本身能沿着诱导人肿瘤细胞凋亡,并对肿瘤细胞生长有明显的抑制作用,本文研究了DMPC/C_<12>(EO)_2<23>杂化脂质体对小鼠肿瘤的治疗作用。DMPC/C_(EO)_2复合脂质体可使小鼠存活率提高150%<12>,且<23>无任何毒副作用。
英文摘要
Hybrid liposomes can be prepared by simply ultrasonicating a mixture of vesicular and micellar molecules in a buffer solution. The physical properties of these liposomes, such as size, membrane fluidity, phase transition temperature, and hydrophobicity can be controlled by changing the composition.The inhibitory effects of hybrid liposomes composed of phospholipids having the same hydrophilic head group (phosphatidylcholine group) and different hydrophobic alkyl chains (L-α-dilauroylphosphatidylcholine (C_<12>: DLPC), L-α-dimyristoylphosphatidylcholine (C_<14>: DMPC), L-α-dipal-mitoylphosphatidylcholine (C_<16>:DPPC)) and polyoxyethylene-dodecyl ether (C_<12>(EO)_<23>) on the growth of human leukemia (HL60) cells in vitro were examined. Hybrid liposomes composed of DMPC and polyoxyethylene (10) dodecyl ether (C_<12>(EO)_<10>) were found to inhibit the growth of human promyelocytic leukemia (HL-60) cells without using any drugs.Induction of apoptosis by hybrid liposomes in HL-60 cells was verified on the basis of fluorescence microscopy and flow cytometry analysis, after fusion and accumulation of hybrid liposomes which was revealed on the basis of microphysiometer. We elucidated the pathways of apoptosis induced by the hybrid liposomes. That is, hybrid liposomes fused and accumulated in tumor cell membranes, and the apoptosis signal first passed through mitochondria, caspase-9 and caspase-3, second through Fas, caspase-8, caspase-3 and then reached the nucleus. Hybrid liposomes themselves can induce apoptosis in human tumor cells along with high inhibitory effects on the growth of tumor cells.We examined therapeutic effects of DMPC/C_<12>(EO)_<23> hybrid liposomes on mice model of carcinoma in vitro. The prolonged survival ratio of 150% was obtained in the treated with hybrid liposomes of DMPC/C_<12>(EO)_<23> without any side effects.
期刊论文(53)
专著(0)
科研奖励(0)
会议论文
Induction of Apoptosis by Hybrid Liposomes without Antitumor Drugs toward Human Breast Tumor Cells
不含抗肿瘤药物的混合脂质体诱导人乳腺肿瘤细胞凋亡
DOI: --
发表时间: 2003
期刊: Journal of Chemical Engineering of Japan 36・9
影响因子: --
作者: [Y Kadota, C.Taniguchi, S.Masuhara, S.Yamamoto, S.Furusaki, M.Iwahara, K.Goto, Y.Matsumoto, R.Ueoka, Yutaka Kadota, Hideaki Nagami]
通讯作者: Hideaki Nagami
抗腫瘍剤、健康食品及び味噌のエタノール抽出物
抗肿瘤剂、保健食品及味噌乙醇提取物
DOI: --
发表时间: 2003
期刊:
影响因子: --
作者: []
通讯作者:
Enzymatic and Hyperglycemia Stability of Chemically Modified Insulins with Hydrophobic Acyl Groups
具有疏水酰基的化学修饰胰岛素的酶稳定性和高血糖稳定性
DOI: --
发表时间: 2004
期刊: Bioorg.Med.Chem.Lett. vol.14 No.4
影响因子: --
作者: [K.Nakashima, M.Miyagi, K.Goto, Y.Matsumoto, R.Ueoka]
通讯作者: R.Ueoka
リポソームによるがん治療と診断
使用脂质体进行癌症治疗和诊断
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [H.Nagami, K.Yamamoto, H.Ichihara, Y.Matsumoto, R.Ueoka, Yoshihiro Yano, Kentaro Nakashima, 上岡龍一]
通讯作者: 上岡龍一
19
    Therapeutic effects of hybrid liposomes against rheumatoid arthritis
    • 批准号:
      15K12527
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2015
    • 负责人:
      MATSUMOTO Yoko
    • 依托单位:
    Development of research with liposomes toward clinical application for cancer and AIDS
    • 批准号:
      23300173
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2011
    • 负责人:
      MATSUMOTO Yoko
    • 依托单位:
    Application and evaluation of proteasome Inhibitor MG132-loaded polymeric micelle using in vivo imaging technique
    • 批准号:
      23791812
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2011
    • 负责人:
      MATSUMOTO Yoko
    • 依托单位:
    Research of Multi-ethnic Coexistence Using Social Simulation as Post-colonial Dialogue
    • 批准号:
      22402048
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2010
    • 负责人:
      MATSUMOTO Yoko
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: